Mauro Martins Teixeira

Research interests

Publications

• Guidance on the planning and reporting of experimental design and analysis

  British Journal of Pharmacology · 2025 · 10.1111/bph.17441

• Planning experiments: Updated guidance on experimental design and analysis and their reporting III

  British Journal of Pharmacology · 2022 · 10.1111/bph.15868

• ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020

  British Journal of Pharmacology · 2020 · https://doi.org/10.1111/bph.15178

• Evolution and epidemic spread of SARS-CoV-2 in Brazil

  Science · 2020 · 10.1126/science.abd2161

• Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production

  Cell Reports · 2020 · 10.1016/j.celrep.2020.02.013

• Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

  British Journal of Pharmacology · 2018 · https://doi.org/10.1111/bph.14153

• ACE inhibition, ACE2 and angiotensin-(17) axis in kidney and cardiac inflammation and fibrosis

  Pharmacological Research · 2016 · 10.1016/j.phrs.2016.03.018

• Resolution of Inflammation: What Controls Its Onset?

  Frontiers in Immunology · 2016 · 10.3389/fimmu.2016.00160

• Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance

  Journal of Immunology Research · 2016 · 10.1155/2016/8239258

• A Role for Gut Microbiota and the Metabolite‐Sensing Receptor GPR43 in a Murine Model of Gout

  Arthritis & Rheumatology · 2015 · 10.1002/art.39107

• Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome

  Nature Communications · 2015 · https://doi.org/10.1038/ncomms7734

• The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases

  Expert Review of Clinical Immunology · 2014 · https://doi.org/10.1586/1744666x.2014.894886

• Targeting CCL5 in inflammation

  Expert Opinion on Therapeutic Targets · 2013 · 10.1517/14728222.2013.837886

• The Role of Probiotics and Prebiotics in Inducing Gut Immunity

  Frontiers in Immunology · 2013 · 10.3389/fimmu.2013.00445

• ACE2 , angiotensin‐(1‐7) and M as receptor axis in inflammation and fibrosis

  British Journal of Pharmacology · 2013 · 10.1111/bph.12159

• Diagnosis and management of Chagas disease and cardiomyopathy

  Nature Reviews Cardiology · 2012 · 10.1038/nrcardio.2012.109

• Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure

  Hepatology · 2012 · 10.1002/hep.25801

• NLRP3 inflammasome–mediated neutrophil recruitment and hypernociception depend on leukotriene B 4 in a murine model of gout

  Arthritis & Rheumatism · 2011 · 10.1002/art.33355

• IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy

  Annals of the Rheumatic Diseases · 2010 · 10.1136/ard.2009.122655

• Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

  Nature · 2009 · https://doi.org/10.1038/nature08530

• Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis

  Proceedings of the National Academy of Sciences · 2009 · 10.1073/pnas.0900196106

• Commensal microbiota is fundamental for the development of inflammatory pain

  Proceedings of the National Academy of Sciences · 2008 · 10.1073/pnas.0711891105

• Crucial role of neutrophils in the development of mechanical inflammatory hypernociception

  Journal of Leukocyte Biology · 2008 · 10.1189/jlb.0907654

• IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4

  The Journal of Immunology · 2008 · 10.4049/jimmunol.181.7.4780

• The Essential Role of the Intestinal Microbiota in Facilitating Acute Inflammatory Responses

  The Journal of Immunology · 2004 · 10.4049/jimmunol.173.6.4137

Current projects

No projects listed.